Adjuvant chemotherapy for resected biliary tract cancers: A fluorouracil-based scheme beats out a gemcitabine-based scheme for the win

Le résumé fourni par la source

1Department of Biliary Surgery, West China Hospital, Sichuan University, Chengdu 610041, China 2Department of Biliary Disease Research Center, West China Hospital of Sichuan University, Chengdu, China Running head: Adjuvant chemotherapy for resected biliary tract cancers Correspondence Yan-Wen Jin, Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China. Add: No. 37 Guo Xue Xiang, Chengdu, Sichuan, 610041, P.R. China. Email: [email protected] Correspondence Fu-Yu Li, Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China. Add: No. 37 Guo Xue Xiang, Chengdu, Sichuan, 610041, P.R. China. Email: [email protected] Supplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal's website, www.hepjournal.com.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.